Ascendis Pharma A (ASND) Receivables Refunds (2016 - 2025)
Historic Receivables Refunds for Ascendis Pharma A (ASND) over the last 12 years, with Q4 2025 value amounting to $2.1 million.
- Ascendis Pharma A's Receivables Refunds rose 931.03% to $2.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $2.1 million, marking a year-over-year increase of 931.03%. This contributed to the annual value of $2.0 million for FY2025, which is 611.33% up from last year.
- Ascendis Pharma A's Receivables Refunds amounted to $2.1 million in Q4 2025, which was up 931.03% from $3.4 million recorded in Q3 2025.
- Over the past 5 years, Ascendis Pharma A's Receivables Refunds peaked at $3.4 million during Q3 2025, and registered a low of $806080.6 during Q1 2024.
- For the 5-year period, Ascendis Pharma A's Receivables Refunds averaged around $1.7 million, with its median value being $1.6 million (2022).
- The largest annual percentage gain for Ascendis Pharma A's Receivables Refunds in the last 5 years was 11981.09% (2024), contrasted with its biggest fall of 2941.72% (2024).
- Over the past 5 years, Ascendis Pharma A's Receivables Refunds (Quarter) stood at $1.0 million in 2021, then decreased by 11.81% to $900878.4 in 2022, then dropped by 4.22% to $862903.8 in 2023, then skyrocketed by 119.81% to $1.9 million in 2024, then increased by 9.31% to $2.1 million in 2025.
- Its last three reported values are $2.1 million in Q4 2025, $3.4 million for Q3 2025, and $3.1 million during Q2 2025.